Abid Ur Rahman: Understanding the Coagulation Cascade and Hemostasis
Abid Ur Rahman, Laboratory Intern at Islamabad Diagnostic Centre, shared a post on LinkedIn:
“Coagulation Cascade Simplified
The coagulation cascade is a complex series of enzymatic reactions that leads to the formation of a stable blood clot to prevent excessive bleeding after vascular injury.
It involves intrinsic, extrinsic, and common pathways, ultimately producing fibrin, which stabilizes the platelet plug.
Phases of Hemostasis
1.Vasoconstriction
- Immediate narrowing of blood vessels after injury
- Reduces blood loss
2.Primary Hemostasis
- Platelets adhere and aggregate at injury site
- Forms temporary platelet plug
3.Secondary Hemostasis (Coagulation Cascade)
- Activation of clotting factors
- Formation of fibrin clot
Extrinsic Pathway (Fast Pathway)
Initiated by tissue injury
Key Factor:
Factor VII (7) and Tissue Factor (Factor III)
Features:
- Rapid activation
- Evaluated by Prothrombin Time (PT/INR)
Pathway:
Tissue injury leads to Tissue Factor exposure, which activates Factor VII, resulting in Factor X activation.
Intrinsic Pathway (Slow Pathway)
Activated by damage within blood vessels
Key Factors:
Factor XII, Factor XI, Factor IX, and Factor VIII
Features:
- Slower but amplifies coagulation
- Evaluated by Activated Partial Thromboplastin Time (APTT)
Pathway:
Activation of Factor XII leads to activation of Factor XI, followed by activation of Factor IX together with Factor VIII, ultimately resulting in Factor X activation.
Common Pathway
Both intrinsic and extrinsic pathways merge here.
Key Factors:
Factor X, Factor V, Prothrombin, and Fibrinogen
Steps:
- Factor X converts Prothrombin into Thrombin
- Thrombin converts Fibrinogen into Fibrin
- Factor XIII stabilizes fibrin clot
Final Result:
Stable fibrin clot formation
Important Clotting Factors
Factor Name
- I Fibrinogen
- II Prothrombin
- III Tissue Factor
- IV Calcium
- VIII Anti-hemophilic factor A
- IX Christmas factor
- X Stuart-Prower factor
Natural Anticoagulants
- Antithrombin
- Protein C and Protein S
- Tissue Factor Pathway Inhibitor (TFPI)
Prevent excessive clot formation
Laboratory Tests Associated
- PT / INR evaluates Extrinsic pathway
- APTT evaluates Intrinsic pathway
- D-dimer reflects Fibrin degradation
- Fibrinogen assay assesses Clotting ability
Clinical Importance
Disorders of coagulation may lead to:
- Excessive bleeding (Hemophilia, DIC)
- Thrombosis (DVT, PE)
- Liver disease-related coagulopathy
- Vitamin K deficiency
Understanding the cascade is essential for interpreting coagulation tests and anticoagulant therapy.
The coagulation cascade transforms vascular injury into controlled clot formation, maintaining the balance between bleeding and thrombosis.”
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear
-
Jul 7, 2026, 20:55Natasa Blagojevic-Stokic: Exploring the Role of ATP and Calcium Homeostasis in Autism
-
Jul 7, 2026, 17:49Alan Nurden: Safer Antithrombotic Therapy Through GPVI
-
Jul 7, 2026, 17:29Anticoagulation Reversal in 2026: Are We Winning the Bleeding Battle? – Francisco Chacón-Lozsán
-
Jul 7, 2026, 17:25Jim Hoffman: Targeting NETosis to Restore Immune Homeostasis
-
Jul 7, 2026, 17:14Shabneez Hussain: Blood Transfusion Professionals Connecting at ISBT 2026